FDA Brief

Warning letters Drugs

FDA warning letter to

Aytu Biopharma

Issued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

False & Misleading Claims/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.

Aytu Biopharma's FDA history

  1. Aytu Biopharma

    False & Misleading Claims/Misbranded

Full company page